ES2534582T3 - Procedimiento para diagnosticar una enfermedad neurodegenerativa - Google Patents
Procedimiento para diagnosticar una enfermedad neurodegenerativa Download PDFInfo
- Publication number
- ES2534582T3 ES2534582T3 ES10182499.3T ES10182499T ES2534582T3 ES 2534582 T3 ES2534582 T3 ES 2534582T3 ES 10182499 T ES10182499 T ES 10182499T ES 2534582 T3 ES2534582 T3 ES 2534582T3
- Authority
- ES
- Spain
- Prior art keywords
- disease
- alzheimer
- expression
- level
- diagnose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
- G01N2333/90605—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4)
- G01N2333/90633—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general
- G01N2333/90638—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general with a definite EC number (1.4.3.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Procedimiento para el diagnóstico de la enfermedad de Alzheimer, que comprende la medición del nivel de expresión de la proteína de la glutatión S-transferasa de tipo silvestre identificada por el número de acceso de SwissProt P78417 en una muestra de plaquetas aisladas de una persona que se sospecha que tiene la enfermedad de Alzheimer, y determinar si el nivel de la expresión está alterado en comparación con un control, en donde un incremento del nivel de expresión de la proteína de la glutatión S-transferasa de tipo silvestre identificada por el número de acceso de SwissProt P78417 cuando se compara con un control sano sin enfermedad indica la presencia de la enfermedad de Alzheimer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0512401 | 2005-06-17 | ||
GBGB0512401.1A GB0512401D0 (en) | 2005-06-17 | 2005-06-17 | Method |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2534582T3 true ES2534582T3 (es) | 2015-04-24 |
Family
ID=34855743
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10182499.3T Active ES2534582T3 (es) | 2005-06-17 | 2006-06-19 | Procedimiento para diagnosticar una enfermedad neurodegenerativa |
ES10183043.8T Active ES2533086T3 (es) | 2005-06-17 | 2006-06-19 | Método para el diagnóstico de una enfermedad neurodegenerativa |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10183043.8T Active ES2533086T3 (es) | 2005-06-17 | 2006-06-19 | Método para el diagnóstico de una enfermedad neurodegenerativa |
Country Status (5)
Country | Link |
---|---|
US (2) | US20080318229A1 (es) |
EP (8) | EP2287617B1 (es) |
ES (2) | ES2534582T3 (es) |
GB (1) | GB0512401D0 (es) |
WO (1) | WO2006134390A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009074331A2 (en) * | 2007-12-11 | 2009-06-18 | Julius-Maximilians-Universität Würzburg | Early and differential diagnosis test for alzheimer's disease |
DE102007062847A1 (de) * | 2007-12-21 | 2009-12-31 | Protagen Ag | Markersequenzen für neurodegenerative Erkrankungen und deren Verwendung |
AU2009205956B2 (en) | 2008-01-18 | 2015-07-02 | President And Fellows Of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
WO2010084327A2 (en) | 2009-01-26 | 2010-07-29 | Electrophoretics Limited | Methods |
GB0906458D0 (en) | 2009-04-15 | 2009-05-20 | Randox Lab Ltd | Macromolecules for diagnosis and prognosis |
GB0921447D0 (en) * | 2009-12-04 | 2010-01-20 | Randox Lab Ltd | Assay |
US20130316338A1 (en) * | 2010-06-29 | 2013-11-28 | The United States Government As Represented By The Department Of Veterans Affairs | CCR6 As A Biomarker of Alzheimer's Disease |
MX361944B (es) | 2010-07-23 | 2018-12-19 | President And Fellows Of Harvard College Star | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. |
SG10201505724SA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
EP2596353A4 (en) | 2010-07-23 | 2014-01-15 | Harvard College | METHOD FOR DETECTING PRENATAL OR PREGNANT DISEASES OR SUFFERING |
AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
GB201104286D0 (en) * | 2011-03-15 | 2011-04-27 | Randox Lab Ltd | Glutathione S-transferase omega 1 wild type specific antibody |
WO2012175674A1 (en) * | 2011-06-24 | 2012-12-27 | Baden-Württemberg Stiftung Ggmbh | Diagnosis and/or prognosis of a neurodegenerative disease |
GB201122227D0 (en) | 2011-12-23 | 2012-02-01 | Randox Lab Ltd | MAO-B inhibitors derived from the one-carbon cycle |
AU2013274002A1 (en) | 2012-06-15 | 2015-02-05 | Harry Stylli | Methods of detecting diseases or conditions |
KR20150035818A (ko) | 2012-06-15 | 2015-04-07 | 해리 스타일리 | 순환 병든 세포를 사용하여 질환 또는 병태를 검출하는 방법 |
GB201212084D0 (en) | 2012-07-06 | 2012-08-22 | Randox Lab Ltd | Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment |
GB201217688D0 (en) | 2012-10-03 | 2012-11-14 | Randox Lab Ltd | Method |
GB2511525A (en) * | 2013-03-05 | 2014-09-10 | Randox Teoranta | Methods and Compositions for the Diagnosis of Alzheimer's Disease |
EP2965086A4 (en) | 2013-03-09 | 2017-02-08 | Harry Stylli | Methods of detecting prostate cancer |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
GB201320164D0 (en) * | 2013-11-15 | 2014-01-01 | Randox Lab Ltd | Sample preparation method for analysis of platelet proteins |
WO2016040843A1 (en) | 2014-09-11 | 2016-03-17 | Harry Stylli | Methods of detecting prostate cancer |
WO2018229278A1 (en) * | 2017-06-16 | 2018-12-20 | Centre Hospitalier Regional Et Universitaire De Lille (Chru) | Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders |
CN114966048A (zh) * | 2022-05-12 | 2022-08-30 | 东南大学 | 血小板AβPP比值在阿尔茨海默病筛查中的应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756479A (en) * | 1994-12-29 | 1998-05-26 | Research Development Foundation | Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase |
EP0874242B2 (en) | 1997-04-21 | 2009-06-03 | Randox Laboratories Ltd. | Device and apparatus for the simultaneous detection of multiple analytes |
NZ516848A (en) * | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
CA2335656A1 (en) * | 1998-07-31 | 2000-02-10 | Incyte Pharmaceuticals, Inc. | Human cytoskeletal proteins |
AU2001261007A1 (en) * | 2000-03-29 | 2001-10-08 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20030064411A1 (en) * | 2000-12-08 | 2003-04-03 | Herath Herath Mudiyanselage Athula Chandrasiri | Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease |
DE10100121A1 (de) * | 2001-01-03 | 2002-08-01 | Henkel Kgaa | Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro |
US7482117B2 (en) * | 2002-12-20 | 2009-01-27 | Celera Corporation | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
WO2005040422A2 (en) * | 2003-10-16 | 2005-05-06 | Novartis Ag | Differentially expressed genes related to coronary artery disease |
TWI281473B (en) * | 2003-12-19 | 2007-05-21 | Ind Tech Res Inst | Biomarkers for liver diseases and method for using same |
WO2005082398A2 (en) * | 2004-02-26 | 2005-09-09 | Ohio University | Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells |
WO2005110460A2 (en) * | 2004-04-29 | 2005-11-24 | Ohio University | Diagnosis and treatment methods related to aging, especially in muscle (14.1) |
EP1797425A2 (en) * | 2004-07-19 | 2007-06-20 | University of Rochester | Biomarkers of neurodegenerative disease |
EP1775590A1 (en) * | 2005-10-11 | 2007-04-18 | Laboratorios S.A.L.V.A.T., S.A. | Non-invasive in vitro method to detect transitional cell carcinoma of the bladder |
-
2005
- 2005-06-17 GB GBGB0512401.1A patent/GB0512401D0/en not_active Ceased
-
2006
- 2006-06-19 EP EP10182533.9A patent/EP2287617B1/en active Active
- 2006-06-19 EP EP10182499.3A patent/EP2339348B1/en active Active
- 2006-06-19 EP EP10183409A patent/EP2293074A3/en not_active Withdrawn
- 2006-06-19 WO PCT/GB2006/002229 patent/WO2006134390A2/en active Application Filing
- 2006-06-19 ES ES10182499.3T patent/ES2534582T3/es active Active
- 2006-06-19 US US11/922,229 patent/US20080318229A1/en not_active Abandoned
- 2006-06-19 ES ES10183043.8T patent/ES2533086T3/es active Active
- 2006-06-19 EP EP10183566A patent/EP2293075A3/en not_active Withdrawn
- 2006-06-19 EP EP10182567.7A patent/EP2287618B1/en active Active
- 2006-06-19 EP EP06744252A patent/EP1891445A2/en not_active Withdrawn
- 2006-06-19 EP EP16150696.9A patent/EP3031823B1/en active Active
- 2006-06-19 EP EP10183043.8A patent/EP2293073B1/en active Active
-
2016
- 2016-02-12 US US15/043,238 patent/US20160161508A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2287618A3 (en) | 2011-05-25 |
EP2287618B1 (en) | 2014-12-31 |
WO2006134390A2 (en) | 2006-12-21 |
EP1891445A2 (en) | 2008-02-27 |
US20080318229A1 (en) | 2008-12-25 |
EP2287617A2 (en) | 2011-02-23 |
EP2339348A2 (en) | 2011-06-29 |
EP2339348A3 (en) | 2011-09-14 |
EP3031823B1 (en) | 2018-12-19 |
EP2287617B1 (en) | 2015-08-12 |
GB0512401D0 (en) | 2005-07-27 |
EP2293073A2 (en) | 2011-03-09 |
EP2293074A3 (en) | 2011-05-04 |
EP2339348B1 (en) | 2015-01-21 |
EP3031823A1 (en) | 2016-06-15 |
ES2533086T3 (es) | 2015-04-07 |
EP2293075A2 (en) | 2011-03-09 |
EP2293075A3 (en) | 2011-05-04 |
WO2006134390A3 (en) | 2007-04-19 |
EP2287618A2 (en) | 2011-02-23 |
EP2287617A3 (en) | 2011-05-18 |
US20160161508A1 (en) | 2016-06-09 |
EP2293073A3 (en) | 2011-09-14 |
EP2293074A2 (en) | 2011-03-09 |
EP2293073B1 (en) | 2014-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2534582T3 (es) | Procedimiento para diagnosticar una enfermedad neurodegenerativa | |
ATE533061T1 (de) | Verfahren zur diagnose bakterieller infektionen | |
AR054479A1 (es) | Metodo para diagnosticar l a enfermedad de alzheimer | |
Anderson et al. | Serotonergic chemosensory neurons modify the C. elegans immune response by regulating G-protein signaling in epithelial cells | |
Montecucco et al. | Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | |
WO2009132058A3 (en) | Levels of bcma protein expression on b cells and use in diagnostic methods | |
BR112012025517A2 (pt) | ____________________________________________________________ anticorpo que reconhece fator inibidor de leucemia (lif) humano e uso de anti-lif anticorpos no tratamento de doenças associadas a proliferação celular não desejada | |
BRPI0512209A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens de um corpo humano ou de animal por formação de imagem óptica, e de monitoração do efeito de tratamento de um corpo humano ou de animal com uma droga para combater uma condição associada com angiogênese | |
BRPI0512932A (pt) | compostos e métodos de identificação e de diagnóstico de paciente como prodrÈmico para doença associada com a deposição amilóide | |
BR0108802A (pt) | Métodos de diagnóstico e terapêuticos para glaucoma | |
ES2570627T3 (es) | Ensayo in vitro de Ezrina para el diagnóstico del cáncer colorrectal | |
ATE451475T1 (de) | Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben | |
ATE511651T1 (de) | Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen | |
ATE406579T1 (de) | Verfahren zur diagnose von tumoren | |
Schreiber et al. | A Caenorhabditis elegans p38 MAP kinase pathway mutant protects from dopamine, methamphetamine, and MDMA toxicity | |
Chen et al. | The first Chinese case of Creutzfeldt-Jakob disease with mutation of E200K in PRNP | |
MX2021007951A (es) | Ensayo multiplexado y metodos de uso del mismo. | |
TR201818373A2 (tr) | Bağirsak mi̇krobi̇yomundan alzhei̇mer hastaliğinin teşhi̇si̇ i̇çi̇n mi̇ni̇mal bi̇yobeli̇rteçler ve i̇lgi̇li̇ yeni̇ nesi̇l di̇zi̇leme ki̇ti̇ | |
DE502006004301D1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum | |
DE602008004556D1 (de) | Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin | |
KR20160007233A (ko) | 폐암 검출용 동물 바이오센서를 이용한 냄새 변별 훈련장치 및 그 용도 | |
DE602005024389D1 (de) | Prognoseverfahren für kongestives herzversagen | |
WO2007058992A3 (en) | Mutations and polymorphisms of hdac6 | |
Chunduri et al. | Oral cysticercosis | |
MX2015013851A (es) | Uso de auto-anticuerpos contra citoqueratina 19 para el diagnostico de cáncer de pulmon. |